AAAAAA

   
Results: 1-7 |
Results: 7
Glutamate receptor dysregulation in the hippocampus of transgenic mice carrying mutated human amyloid precursor protein
Authors: Cha, JHJ Farrell, LA Ahmed, SF Frey, A Hsiao-Ashe, KK Young, AB Penney, JB Locascio, JJ Hyman, BT Irizarry, MC
Citation: Jhj. Cha et al., Glutamate receptor dysregulation in the hippocampus of transgenic mice carrying mutated human amyloid precursor protein, NEUROBIOL D, 8(1), 2001, pp. 90-102
A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's disease
Authors: Shoulson, I Penney, J McDermott, M Kieburtz, K Schwid, SR Kayson, E Chase, T Fahn, S Greenamyre, JT Lang, A Siderowf, A Pearson, N Harrison, M Rost-Ruffner, E Colcher, A Lloyd, M Matthews, M Pahwa, R McGuire, D Lew, MF Schuman, S Marek, K Broshjeit, S Factor, S Brown, D Feigin, A Mazurkiewicz, J Ford, B Jennings, D Dillon, S Comella, C Blasucci, L Janko, K Shulman, L Wiener, W Bateman-Rodriguez, D Carrion, A Suchowersky, O Lafontaine, AL Pantella, C Siemers, E Belden, J Davies, R Lannon, M Grimes, D Gray, P Martin, W Kennedy, L Adler, C Newman, S Hammerstad, J Stone, C Lewitt, P Bardram, K Mistura, K Miyasaki, J Johnston, L Cha, JHJ Tennis, M Panisset, M Hall, J Tetrud, J Friedlander, J Hauser, R Gauger, L Rodnitzky, R Deleo, A Dobson, J Seeberger, L Dingmann, C Tarsy, D Ryan, P Elmer, L Ruzicka, D Stacy, M Brewer, M Locke, B Baker, D Casaceli, C Day, D Florack, M Hodgeman, K Laroia, N Nobel, R Orme, C Rexo, L Rothenburgh, K Sulimowicz, K Watts, A Wratni, E Tariot, P Cox, C Leventhal, C Alderfer, V Craun, AM Frey, J McCree, L McDermott, J Cooper, J Holdich, T Read, B
Citation: I. Shoulson et al., A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's disease, NEUROLOGY, 56(4), 2001, pp. 455-462
Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease
Authors: Chen, M Ona, VO Li, MW Ferrante, RJ Fink, KB Zhu, S Bian, J Guo, L Farrell, LA Hersch, SM Hobbs, W Vonsattel, JP Cha, JHJ Friedlander, RM
Citation: M. Chen et al., Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease, NAT MED, 6(7), 2000, pp. 797
Decreased expression of striatal signaling genes in a mouse model of Huntington's disease
Authors: Luthi-Carter, R Strand, A Peters, NL Solano, SM Hollingsworth, ZR Menon, AS Frey, AS Spektor, BS Penney, EB Schilling, G Ross, CA Borchelt, DR Tapscott, SJ Young, AB Cha, JHJ Olson, JM
Citation: R. Luthi-carter et al., Decreased expression of striatal signaling genes in a mouse model of Huntington's disease, HUM MOL GEN, 9(9), 2000, pp. 1259-1271
Transcriptional dysregulation in Huntington's disease
Authors: Cha, JHJ
Citation: Jhj. Cha, Transcriptional dysregulation in Huntington's disease, TRENDS NEUR, 23(9), 2000, pp. 387-392
Altered neurotransmitter receptor expression in transgenic mouse models ofHuntington's disease
Authors: Cha, JHJ Frey, AS Alsdorf, SA Kerner, JA Kosinski, CM Mangiarini, L Penney, JB Davies, SW Bates, GP Young, AB
Citation: Jhj. Cha et al., Altered neurotransmitter receptor expression in transgenic mouse models ofHuntington's disease, PHI T ROY B, 354(1386), 1999, pp. 981-989
Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease
Authors: Ona, VO Li, MW Vonsattel, JPG Andrews, LJ Khan, SQ Chung, WM Frey, AS Menon, AS Li, XJ Stieg, PE Yuan, JY Penney, JB Young, AB Cha, JHJ Friedlander, RM
Citation: Vo. Ona et al., Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease, NATURE, 399(6733), 1999, pp. 263-267
Risultati: 1-7 |